Loading...
Loading...
Application UK00801501237 · Registered

| Application Number | UK00801501237 |
| Status | Registered |
| Owner | Mesoblast International Sàrl |
| Filed | 2019-09-18 |
| Registered | 2020-06-25 |
| Renewal Due | 2029-09-18 |
| Type | Individual |
| Feature | Figurative |
| Attorney | See claim section below |
Yes. UK00801501237 is currently a registered UK trademark, with renewal due on 2029-09-18. It is protected under UK intellectual property law and can be enforced against infringing uses.
The mark consists of a stylized six-point design, formed by six lines made up of four circles increasing in size away from a center circle point.
The specification below is taken directly from the filed record at the UK IPO for each Nice class this trademark is registered in.
Pharmaceutical, biotechnology and medication preparations and substances for the prevention, management, diagnosis, and treatment of inflammatory and/or degenerative disorders and conditions for medical and surgical purposes.
Scientific research, clinical research, and development services in relation to pharmaceutical preparations and medicines; advisory and consultancy services in the fields of pharmaceutical research and development.
This figurative mark is indexed under the following Vienna categories by the UK IPO:
This device mark (application number UK00801501237) is a registered trademark on the UK IPO register, filed by Mesoblast International Sàrl on 18 September 2019, with registration granted on 25 June 2020. It is due to expire on 18 September 2029.
This mark is recorded under multiple classes: Class 5 (pharmaceuticals & medical preparations); Class 42 (scientific, IT & design services), specifically covering: The mark consists of a stylized six-point design, formed by six lines made up of four circles increasing in size away from a center circle point.
The trademark is represented by Monica Riva Talley Sterne, Kessler, Goldstein & Fox P.L.L.C..
Yes — the UK IPO records UK trademark UK00801501237 as registered.
UK trademark UK00801501237 is recorded in Class 5 (pharmaceuticals & medical preparations); Class 42 (scientific, IT & design services). The filed specification reads: Class 5: Pharmaceutical, biotechnology and medication preparations and substances for the prevention, management, diagnosis, and treatment of inflammatory and/or degenerative disorders and conditions for medical and surgical purposes. | Class 42: Scientific research, clinical research, and development services in re…
UK trademark UK00801501237 was filed at the UK IPO on 18 September 2019 and registered on 25 June 2020.
UK trademark UK00801501237 is currently recorded as valid until 18 September 2029, at which point it will need to be renewed with the UK IPO to remain in force.
Monica Riva Talley Sterne, Kessler, Goldstein & Fox P.L.L.C. is listed as the attorney / representative of record for UK trademark UK00801501237 on the UK IPO register.
This trademark has an attorney of record listed on the UK register. The firm has not yet claimed its listing on Trademark Dashboard.
UK trademark data is supplied by the Intellectual Property Office under the Open Government Licence v3.0.
The “About This Trademark” summary and FAQ above are AI-generated from the register data shown on this page. They are factual summaries only — always verify details against the official register before making legal decisions.